Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Brandon Ingram exits Raptors playoff game early

April 29, 2026

Motorola just revealed the Razr Fold’s price and hoo boy

April 29, 2026

PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results

April 29, 2026

Pure Mate Launches World’s First Botanical Wellness Diffuser with Smart LCD Tracking

April 29, 2026

Did you know Elk Island National Park has black bears?

April 29, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » 2024 Research Report | Hematology Analyzers and Reagents Market Anticipated to Reach USD 8.8 Billion by 2029
Press Release

2024 Research Report | Hematology Analyzers and Reagents Market Anticipated to Reach USD 8.8 Billion by 2029

By News RoomSeptember 5, 20243 Mins Read
2024 Research Report | Hematology Analyzers and Reagents Market Anticipated to Reach USD 8.8 Billion by 2029
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) — The “Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The global hematology analyzers and reagents market, currently valued at USD 6.6 billion, is anticipated to exhibit a compound annual growth rate of 6.1% to achieve a valuation of USD 8.8 billion by the year 2029

This robust growth is primarily driven by continuous technological advancements within the field. The increasing prevalence of blood disorders and the rising integration of advanced technologies such as flow cytometry in hematology analyzers are further expected to fuel market expansion.

The expansive product portfolio of hematology analyzers and reagents is categorized into hematology products & services, hemostasis products & services, and immunohematology products & services. Dominance is projected for the hematology products & services segment, driven by the enhanced adoption rates of point-of-care testing analyzers and the introduction of innovative hematology products globally.

In terms of pricing, low-range hematology analyzers are set to capture the largest market share, with their cost-effectiveness poised to appeal to a broader spectrum of healthcare facilities when compared to their high-range counterparts.

End-User Insights

Commercial service providers are anticipated to account for a significant share, as outsourcing of research and development activities, particularly in emerging economies, gains more traction. Hospitals, government labs, and blood banks also represent crucial end-user segments contributing to the market growth.

Regional Analysis

Geographically, North America holds a significant market share due to its advanced healthcare infrastructure and high adoption rates of innovative technologies. However, it is the Asia Pacific region that is expected to register the fastest growth, presenting lucrative market penetration opportunities driven by burgeoning economic development and an increasing emphasis on healthcare modernization.

Competitive Landscape

The market is characterized by a diverse mix of players, ranging from established industry giants to emergent entities, all competing to consolidate their position in this dynamic sector. These organizations continue to advance the field through innovation, seeking to address the unmet needs within hematology diagnostics.

The global hematology analyzers and reagents market is poised for a sustained period of growth, underpinned by technological enhancements and a deepening understanding of hematology diagnostics’ pivotal role in healthcare. This market’s trajectory suggests that the industry will continue to experience substantial progress and expansion through to 2029.

Key Attributes:

Report Attribute Details
No. of Pages 309
Forecast Period 2024 – 2029
Estimated Market Value (USD) in 2024 $6.6 Billion
Forecasted Market Value (USD) by 2029 $8.8 Billion
Compound Annual Growth Rate 6.1%
Regions Covered Global

Companies Featured

  • Sysmex Corporation
  • Danaher Corporation
  • Siemens Healthineers
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Abbott Laboratories
  • Diatron
  • Drew Scientific
  • Bio-Rad Laboratories, Inc. & Enhancements
  • Horiba, Ltd. & Approvals
  • Nihon Kohden Corporation
  • Ekf Diagnostics Holdings PLC
  • Boule Diagnostics Ab
  • F. Hoffmann-La Roche Ltd.
  • Biosystems
  • Quidelortho Corporation
  • Drucker Diagnostics
  • Elitech Group Sas
  • Accurex
  • Streck
  • Neomedica
  • Cpc Diagnostics Pvt. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Shenzhen Dymind Biotechnology Co. Ltd.
  • Pz Cormay SA
  • Pixcell Medical
  • Rayto Life and Analytical Sciences Co. Ltd.
  • Analyticon Biotechnologies GmbH
  • Tulip Diagnostics (P) Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/p0iofd

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Hematology Analyzers and Reagents Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Pure Mate Launches World’s First Botanical Wellness Diffuser with Smart LCD Tracking

Crypto News Today: AlphaPepe Presale Crosses 8,100 Holders as Dogecoin Price Prediction Questions Whether DOGE Price Can Push to $10

Concurrent Technologies Corporation Secures $18 Million AFRL Contract to Advance Energy Storage Solutions for Air Force Missions

AI Enters the Group Chat: Startup Shapes Emerges from Stealth with $8M Seed Round, Addresses AI Psychosis with First App Where You Can Talk to AI with Friends

DXD Capital Provides Wealth Managers Access to Its Latest Self Storage Fund via iCapital Marketplace

Fathers care now more than ever, but caring has never been harder – new study reveals half of the world’s fathers and mothers feel unsupported by society as they care for loved ones

G Hughes Relaunches with Refreshed Brand Identity and New Globally Inspired Sauces

HEINEKEN strengthens global capability footprint with official opening of Business Services Centre in India

Editors Picks

Motorola just revealed the Razr Fold’s price and hoo boy

April 29, 2026

PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results

April 29, 2026

Pure Mate Launches World’s First Botanical Wellness Diffuser with Smart LCD Tracking

April 29, 2026

Did you know Elk Island National Park has black bears?

April 29, 2026

Latest News

Crypto News Today: AlphaPepe Presale Crosses 8,100 Holders as Dogecoin Price Prediction Questions Whether DOGE Price Can Push to $10

April 29, 2026

Concurrent Technologies Corporation Secures $18 Million AFRL Contract to Advance Energy Storage Solutions for Air Force Missions

April 29, 2026

Elon Musk’s worst enemy in court is Elon Musk

April 29, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version